Pulmonx Corp (LUNG) support and resistance · rev $83.8M
Pulmonx Corp (LUNG) is a medical devices company listed on US.
This page maps Pulmonx Corp (LUNG) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LUNG revenue for 2024-12-31 was $83.8M. Net income was -$56.4M. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. LUNG currently screens at market cap $111.9M.
LUNG currently screens at market cap $111.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LUNG 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LUNG quote page for the session range and the stock page for the full model.
Not investment advice.